Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alzheimer's disease
Biotech
Sage scraps Alzheimer's program as dalzanemdor goes 0 for 2
The biotech axed its Alzheimer’s plans after seeing midphase data, adding to a Parkinson’s flop and turning focus to an upcoming Huntington’s readout.
Nick Paul Taylor
Oct 8, 2024 8:34am
Cassava pays $40M over allegedly misleading Alzheimer's update
Sep 27, 2024 9:20am
NIH leader's research misconduct calls drugs into question
Sep 26, 2024 9:12am
After Alzheimer's stumble, Athira lays off 70% of workforce
Sep 20, 2024 2:41pm
Potential new Alzheimer's drugs target tangles of tau
Sep 19, 2024 2:42pm
GE HealthCare claims FDA clearance for amyloid imaging software
Sep 18, 2024 11:00am